Modena, D.; Moras, M.L.; Sandrone, G.; Stevenazzi, A.; Vergani, B.; Dasgupta, P.; Kliever, A.; Gulde, S.; Marangelo, A.; Schillmaier, M.;
et al. Identification of a Novel SSTR3 Full Agonist for the Treatment of Nonfunctioning Pituitary Adenomas. Cancers 2023, 15, 3453.
https://doi.org/10.3390/cancers15133453
AMA Style
Modena D, Moras ML, Sandrone G, Stevenazzi A, Vergani B, Dasgupta P, Kliever A, Gulde S, Marangelo A, Schillmaier M,
et al. Identification of a Novel SSTR3 Full Agonist for the Treatment of Nonfunctioning Pituitary Adenomas. Cancers. 2023; 15(13):3453.
https://doi.org/10.3390/cancers15133453
Chicago/Turabian Style
Modena, Daniela, Maria Luisa Moras, Giovanni Sandrone, Andrea Stevenazzi, Barbara Vergani, Pooja Dasgupta, Andrea Kliever, Sebastian Gulde, Alessandro Marangelo, Mathias Schillmaier,
and et al. 2023. "Identification of a Novel SSTR3 Full Agonist for the Treatment of Nonfunctioning Pituitary Adenomas" Cancers 15, no. 13: 3453.
https://doi.org/10.3390/cancers15133453
APA Style
Modena, D., Moras, M. L., Sandrone, G., Stevenazzi, A., Vergani, B., Dasgupta, P., Kliever, A., Gulde, S., Marangelo, A., Schillmaier, M., Luque, R. M., Bäuerle, S., Pellegata, N. S., Schulz, S., & Steinkühler, C.
(2023). Identification of a Novel SSTR3 Full Agonist for the Treatment of Nonfunctioning Pituitary Adenomas. Cancers, 15(13), 3453.
https://doi.org/10.3390/cancers15133453
